Cargando…

Corrigendum to Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369174/ https://www.ncbi.nlm.nih.gov/pubmed/32694906 http://dx.doi.org/10.21147/j.issn.1000-9604.2020.03.13

Ejemplares similares

Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing
por: Xiang, Hongyu, et al.
Publicado: (2020)

Clinical analysis of 21-gene relapse score test in hormone receptor-positive early-stage breast cancer
por: Zhu, Lizhe, et al.
Publicado: (2021)

Clinicopathological and Gene Mutation Analysis of 27 Cases with Extranodal Rosai–Dorfman Disease [Corrigendum]
Publicado: (2022)

Corrigendum to “Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer”
por: Harpaz, Noa, et al.
Publicado: (2020)

Corrigendum to Clinicopathologic Analysis of Oral Squamous Cell Carcinoma After 125I Interstitial Brachytherapy
Publicado: (2020)

Corrigendum to “Clinicopathological Characteristics and Prognosis of Papillary Thyroid Carcinoma in Naturally Menopausal Women with Various Durations of Premenarche, Reproductive Periods, and Postmenopausal Stages”
por: Zhu, Xu-Hang, et al.
Publicado: (2018)

Reduced butyrylcholinesterase activity is an early indicator of trauma-induced acute systemic inflammatory response [Corrigendum]
Publicado: (2017)

Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer”
por: Hess, Timo, et al.
Publicado: (2023)

Corrigendum: Health monitoring and health indicators in Europe
por: Fehr, Angela, et al.
Publicado: (2018)

Corrigendum: Genetic testing in neurology exploiting next generation sequencing: state of art
Publicado: (2020)

Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
Publicado: (2019)

Corrigendum to: Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study
por: Fatayer, Hiba, et al.
Publicado: (2022)

Corrigendum: Developments in the health situation in Germany during the initial stage of the COVID-19 pandemic for selected indicators of GEDA 2019/2020-EHIS
por: Damerow, Stefan, et al.
Publicado: (2021)

Corrigendum to: Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis
por: Saw, Kai Sheng, et al.
Publicado: (2022)

Corrigendum to “Recent Advances in Microwave Imaging for Breast Cancer Detection”
por: Kwon, Sollip, et al.
Publicado: (2018)

Corrigendum to “High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer”
por: Yang, Long, et al.
Publicado: (2019)

The role of taxanes in triple-negative breast cancer: literature review [Corrigendum]
Publicado: (2015)

Corrigendum for The clinicopathological and microRNA expression signature associated with lymphovascular invasion in squamous cell carcinoma: a basic descriptive study
Publicado: (2022)

Corrigendum to: ABO Genetic Variation in Neanderthals and Denisovans
por: Villanea, Fernando A, et al.
Publicado: (2021)

Corrigendum to The Effect of Acupuncture in Breast Cancer–Related Lymphoedema (BCRL): A Systematic Review and Meta-Analysis
Publicado: (2019)

Corrigendum to “Automatic Fruit Morphology Phenome and Genetic Analysis: An Application in the Octoploid Strawberry”
por: Zingaretti, Laura M., et al.
Publicado: (2022)

Corrigendum to: Variation in financial protection and its association with health expenditure indicators: an analysis of low- and middle-income countries
por: Anjorin, Seun S, et al.
Publicado: (2021)

Corrigendum to “Early Detection of Medical Image Analysis by Using Machine Learning Method”
por: Khasawneh, Ahmad M., et al.
Publicado: (2022)

Corrigendum to: Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation
Publicado: (2020)

Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum]
Publicado: (2017)

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
Publicado: (2015)

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
Publicado: (2018)

The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy [Corrigendum]
Publicado: (2019)

A Proposed COVID-19 Testing Algorithm–Corrigendum
por: Hart, Alexander, et al.
Publicado: (2020)

Genetics of substance use disorders: a review – CORRIGENDUM
por: Deak, Joseph D., et al.
Publicado: (2022)

Corrigendum to “Breast Cancer Survival and Incidence: 10 Years Cancer Registry Data in the Northwest, Iran”
por: Dolatkhah, Roya, et al.
Publicado: (2021)

Corrigendum to: Fear boosts the early neural coding of faces
por: Turano, Maria Teresa, et al.
Publicado: (2017)

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer [Corrigendum]
Publicado: (2022)

Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum]
Publicado: (2023)

Corrigendum to A stage-specific cell-manipulation platform for inducing endothelialization on demand
por: Zhao, Qilong, et al.
Publicado: (2021)

Repetitive Saliva Swallowing Test Predicts COPD Exacerbation [Corrigendum]
Publicado: (2021)

Corrigendum to: Epicardial ablation in genetic cardiomyopathies: a new frontier
Publicado: (2019)

Corrigendum to “Genetic Diversity in Drug Transporters: Impact in African Populations”
Publicado: (2021)

Predictors of Depression, Anxiety and Stress Indicators in a Cohort of Women with Chronic Pelvic Pain [Corrigendum]
Publicado: (2020)

Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis [Corrigendum]
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iuksu7c6234hn8g2r1i36ojq7a